DOI : 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

Issue 09 · Volume 116 · September 2008 DOI: 10.1055/s-002-13344


12th Annual Meeting of the Neuroendocrinology Section of the German Society of Endocrinology (DGE)
Bamberg, Germany, 24, October 2008


Abstracts (HTML) List of Authors
  • P23
    Schaaf, C.; Perone, M.; Labeur, M.; Theodoropoulou, M.; Corrêa-de-Santana, E.; Arzt, E.; Stalla, G. K.; Renner, U.:

    Impact of curcumin on growth and apoptosis of pituitary tumor cells

  • P24
    Corrêa-de-Santana, E.; Theodoropoulou, M.; Fröhlich, B.; Paez-Pereda, M.; Monteserin Garcia, J. L.; Onofri, C.; Labeur, M.; Renner, U.; Stalla, G. K.:

    NOD proteins expression and function in the pituitary folliculostellate cells

  • P25
    Shan, B.; Onofri, C.; Theodoropoulou, M.; Arzt, E.; Stalla, G. K.; Renner, U.:

    Expression of HIF-1a and VEGF in human pituitary tumors and rodent pituitary tumor cell lines under hypoxia-mimicking condition

  • P26
    Mayr, B.; Buchfelder, M.; Schöfl, C.:

    Activation of calcium and cAMP-signalling in GH-secreting pituitary adenomas

  • P27
    Cerovac, V.; Monteserin Garcia, J. L.; Stalla, G. K.; Theodoropoulou, M.:

    Octreotide restricts GH-secreting tumor growth by inhibiting mTOR

  • P28
    Tanase, C.; Codorean, E.; Raducan, E.; Popescu, I. D.; Tanase, M.; Ogrezeanu, I.; Cruceru, M. L.; Hinescu, M.:

    Role of Apaf-1 and cathepsin B in pituitary tumor progression

  • P29
    Sievers, C.; Dimopoulou, C.; Pfister, H.; Roemmler, J.; Schopohl, J.; Schneider, H. J.; Zihl, J.; Stalla, G. K.:

    Cognitive dysfunction in acromegaly: a clinical study in 55 patients

  • P30
    Dimopoulou, C.; Sievers, C.; Sprenger, T.; Roemmler, J.; Schopohl, J.; Stalla, G. K.:

    Pain characteristics in acromegalic patients compared to patients with non-functioning pituitary adenomas

  • P31
    Roemmler, J.; Schneider, H. J.; Bidlingmaier, M.; Schopohl, J.:

    Leptin serum levels during an oral glucose tolerance test in growth hormone deficiency and acromegaly

  • P32
    Berg, C.; Meinel, T.; Yüce, A.; Lahner, H.; Mann, K.; Petersenn, S.:

    Dynamic testing after pituitary surgery: is follow-up re-testing useful?

  • P33
    Berg, C.; Meinel, T.; Yüce, A.; Lahner, H.; Mann, K.; Petersenn, S.:

    Prospective comparison of the glucagon stimulation test (GST) with the insulin tolerance test (ITT) in patients following pituitary surgery

  • P34
    Arafat, A. M.; Möhlig, M.; Weickert, M. O.; Perschel, F. H.; Purschwitz, J.; Spranger, J.; Strasburger, C. J.; Schöfl, C.; Pfeiffer, A. F. H.:

    A comparison between three automated chemiluminescence assays for growth hormone: on the use of recombinant hGH as a primary calibrant

  • P35
    Meyer, S.; Köhler, U.; Plöckinger, U.; Stalla, G. K.; Tuschy, U.; Kann, P. H.:

    Common insulin-like growth factor 1 (IGF-1) gene polymorphisms are not associated with the growth hormone (GH)-dose in adults with GH-deficiency

  • P36
    Psaras, T.; Buslei, R.; Saeger, W.; Klein, D.; Capper, D.; Meyermann, R.; Mittelbronn, M.; Honegger, J.:

    Atypical type II silent corticotrophic adenoma developing into Cushing's disease upon second recurrence

  • P37
    Schneider, H. J.; Schneider, M.; Kreitschmann-Andermahr, I.; Tuschy, U.; Wallaschofski, H.; Faust, M.; Renner, C.; Kopczak, A.; Jordan, M.; Saller, B.; Buchfelder, M.; Stalla, G. K.:

    Structured assessment of neuroendocrine dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage in 1112 patients – the German interdisciplinary database

  • P38
    Kopczak, A.; Killimann, I.; Rosen, F. von; Schneider, H. J.; Stalla, G. K.; Schneider, M.:

    Hypophysenscreening nach Schädel-Hirn-Trauma und Subarachnoidalblutung – Erfahrungen in einer neurologischen Klinik

  • P39
    Larrosa, S.; Droste, S.; Harati, A.; Scholz, M.; Dietrich, J.; Range, I.; Klein, H. H.; Hering, S.:

    Hypophysenfunktionsstörung nach SAB: Erste Ergebnisse einer retrospektiven Untersuchung bezüglich der Inzidenz von Hormonstörungen

  • P40
    Kreutzer, J.; Kleindienst, A.; Akutsu, H.; Bidlingmaier, M.; Schöfl, C.; Buchfelder, M.:

    Pituitary deficiency 3 and 12 months after traumatic brain injury or subarachnoid hemorrhage – A prospective longitudinal study on pituitary function using different methods of dynamic neuroendocrine evaluation

  • P41
    Junge, T.; Fleck, S.; Albrecht, C.; Nauck, M.; Wallaschofski, H.; Schröder, H. S.:

    Pituitary dysfunction in patients operated on for non-pituitary intracranial tumors – a retrospectic clinical study

  • P42
    Friedrich, N.; Haring, R.; Nauck, M.; Lüdemann, J.; Rosskopf, D.; Spilcke-Liss, E.; Felix, S. B.; Dörr, M.; Brabant, G.; Völzke, H.; Wallaschofski, H.:

    Serum insulin-like growth factor I, insulin-like growth factor binding protein 3 and mortality: results of the Study of Health in Pomerania (SHIP)

  • P43
    Spilcke-Liss, E.; Friedrich, N.; Dörr, M.; Nauck, M.; Brabant, G.; Schmincke, U.; Völzke, H.; Wallaschofski, H.:

    Serum insulin-like growth factor 1, insulin-like growth factor binding protein 3 and intima media thickness: results of the Study of Health in Pomerania (SHIP)

  • P44
    Steveling, A.; Haring, R.; Felix, S. B.; Nauck, M.; Dörr, M.; Völzke, H.; Wallaschofski, H.:

    No association between increased prolactin levels and progression of left ventricular mass in German cohort study

  • P45
    Moock, J.; Haring, R.; Kohlmann, T.; Völzke, H.; Nauck, M.; Wallaschofski, H.:

    Subjective health and mortality in a population-based cohort: Study of Health In Pomerania (SHIP)

  • P46
    Bazarra-Castro, M. A.; Sievers, C.; Dimopoulou, C.; Stalla, G. K.:

    Hormonal treatment effects in transsexuals: a survey at the Max Planck Institute of Psychiatry (MPIP) in Munich

  • P47
    Kausel, G.; Cortes, M.; Horning, Y.; Munoz, A.; Vera, T.; Romero, A.; Figueroa, J.:

    Metal responsive transcription factor MTF-1 spatial expression related to functional organization of pituitary cells in Cyprinus carpio

  • P48
    Guerriero, G.; Ciarcia, G.:

    Reptile (Podarcis sicula) brain progesterone receptor: relationship to plasma steroids and vitellogenic cycle during Gonadal recrudescence